Latest News for: Beijing therapy

Edit

Peripheral Artery Disease Market to Witness Upsurge in Growth During the Forecast Period | Ixaka ...

GetNews 25 Apr 2024
Key Peripheral Artery Disease companies working in the peripheral artery disease market who are in different phases of developing therapies are - NovoNordisk, Takeda, Mercator MedSystems, Inc., Beijing Northland Biotech.
Edit

Pertussis Market Analysis 2032: Epidemiology, FDA Approvals, Clinical Trials, Therapies, Companies by DelveInsight | Sanofi ...

GetNews 18 Apr 2024
Major key companies are working proactively in the Pertussis Therapeutics market to develop novel therapies which will drive the Pertussis treatment markets in the upcoming years are Sanofi Pasteur, ...
Edit

Hemophilia Market Size in the 7MM is Expected to Grow by 2032 | DelveInsight

GetNews 17 Apr 2024
Scope of the Hemophilia Market Research Report Coverage- 7MM Hemophilia Companies- ApcinteX, ASC Therapeutics, Ultragenix Pharmaceutical, BioMarin Pharmaceutical, CSL Behring, Freeline Therapeutics, ...
Edit

Lack of drug-susceptibility data for TB can compromise treatment outcomes: study

Indian Express 17 Apr 2024
The predominant lineage was the Beijing genotype (39.5%) followed by Delhi-CAS (36.66%) and EAI (14.50%) 55% in the age group from 15-35 years and 67% in the age group up to 14 years had pre-XDR TB.
Edit

Hemophilia A Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therapies and Companies by DelveInsight | ...

GetNews 16 Apr 2024
Key Takeaways from the Hemophilia A Pipeline Report Over 40+ Hemophilia A pipeline therapies are in various stages of development, and their anticipated acceptance in the Hemophilia A market would significantly increase market revenue.
Edit

Acute Liver Failure Market Size is Expected to Grow by 2032 | DelveInsight

GetNews 16 Apr 2024
The leading Acute Liver Failure Companies working in the market include Vital Therapies, AstraZeneca, Bristol-Myers Squibb, Beijing Continent Pharmaceutical Co, Ltd., GE Healthcare, Sinew Pharma Inc., ...
Edit

Education shouldn't just be about getting high exam scores

China Daily 04 Mar 2024
I was lying face down on a massage table, getting acupuncture and cupping therapy for my aching waist in a hospital in Beijing last week. In the room were a male doctor and two women patients ... It is very helpful." ... kangbing@chinadaily.com.cn. .
Edit

Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark ...

GetNews 01 Mar 2024
Key Takeaways from the Hemophilia A Pipeline Report Over 40+ Hemophilia A pipeline therapies are in various stages of development, and their anticipated acceptance in the Hemophilia A market would significantly increase market revenue.
Edit

Thrombotic Thrombocytopenic Purpura Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight ...

GetNews 29 Feb 2024
Sanofi, Carelon Research, Archemix Corp., Eisai Inc., Biopharma Plasma, Beijing InnoCare Pharma, Shionogi, Takeda, and others Key Thrombotic Thrombocytopenic Purpura Therapies ... Purpura Therapies.
Edit

COVID-19 Competitive Landscape 2023 (Updated)

GetNews 28 Feb 2024
Key Takeaways from the COVID-19 Report DelveInsight’s COVID-19 report depicts a robust space with 400+ active players working to develop 500+ pipeline therapies for COVID-19 treatment ... COVID-19 Companies and Therapies Nobelpharma.
Edit

Update: Chinese scientist awarded for groundbreaking work in transplantation, cellular therapy

Xinhua 25 Feb 2024
23, 2024 for his groundbreaking work known as Beijing Protocol in transplantation and cellular therapy ... his groundbreaking work known as Beijing Protocol in the transplantation and cellular therapy.
photo: World Economic Forum / Benedikt von Loebell
World Economic Forum Annual Meeting
Edit

Argentina drinking poison to quench thirst with shock therapy

China Daily 23 Jan 2024
Edit

Future industries spur China's economic engine

China Daily 05 Jan 2024
BEIJING — A group of Chinese researchers has created a gene target therapy drug for amyotrophic lateral sclerosis, or ALS ... Cell and gene therapy is a potential future business for Beijing ... Beijing's ...
Edit

Manhattan Biosolutions Enters Into Evaluation And Potential Licensing Agreement With Biocytogen

MENA FN 04 Jan 2024
(MENAFN - Market Press Release) January 3, 2024 2.34 am - Use of Innovative Antibodies in Targeted Therapies New York City, New York and Beijing, China, January 3, 2024 - Manhattan BioSolutions, ... .
×